GP-Act III Acquisition (GPAT) Competitors $10.18 +0.01 (+0.05%) As of 10:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends GPAT vs. AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, AITRU, and AITRRShould you be buying GP-Act III Acquisition stock or one of its competitors? The main competitors of GP-Act III Acquisition include AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), AI Transportation Acquisition (AITRU), and AI Transportation Acquisition (AITRR). These companies are all part of the "trading" industry. GP-Act III Acquisition vs. AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition AI Transportation Acquisition GP-Act III Acquisition (NASDAQ:GPAT) and AGBA Group (NASDAQ:AGBAW) are both finance, insurance, and real estate companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, community ranking, earnings, valuation and analyst recommendations. Is GPAT or AGBAW more profitable? Company Net Margins Return on Equity Return on Assets GP-Act III AcquisitionN/A N/A N/A AGBA Group N/A N/A N/A Does the media favor GPAT or AGBAW? In the previous week, GP-Act III Acquisition's average media sentiment score of 0.00 equaled AGBA Group'saverage media sentiment score. Company Overall Sentiment GP-Act III Acquisition Neutral AGBA Group Neutral Which has stronger earnings & valuation, GPAT or AGBAW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGP-Act III AcquisitionN/AN/AN/AN/AN/AAGBA Group$38.55MN/AN/AN/AN/A Does the MarketBeat Community prefer GPAT or AGBAW? GP-Act III Acquisition and AGBA Group both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformGP-Act III AcquisitionN/AN/AAGBA GroupN/AN/A SummaryAGBA Group beats GP-Act III Acquisition on 1 of the 1 factors compared between the two stocks. Get GP-Act III Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for GPAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GPAT vs. The Competition Export to ExcelMetricGP-Act III AcquisitionInvestment Offices IndustryFinance, Insurance, And Real Estate SectorNASDAQ ExchangeMarket CapN/A$19.34M$10.63B$9.13BDividend YieldN/AN/A0.85%4.00%P/E RatioN/AN/A2.8617.53Price / SalesN/AN/A16.63134.29Price / CashN/AN/AN/A32.90Price / BookN/AN/AN/A4.69Net IncomeN/AN/AN/A$224.57M7 Day Performance0.05%-2.36%0.43%1.69%1 Month Performance0.35%0.88%3.08%5.34%1 Year PerformanceN/A-2.93%17.16%21.47% GP-Act III Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GPATGP-Act III AcquisitionN/A$10.18+0.0%N/AN/A$0.00N/A0.00N/AAGBAWAGBA GroupN/A$0.21+18.3%N/AN/A$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$24.73+0.7%N/A+8.4%$0.00$1.26B0.0050Positive NewsAGNCOAGNC InvestmentN/A$25.25+0.4%N/A+4.6%$0.00$1.26B0.0050Positive NewsAGNCNAGNC InvestmentN/A$25.570.0%N/A+1.6%$0.00$1.26B0.0050Positive NewsAGNCMAGNC InvestmentN/A$25.01flatN/A+4.5%$0.00$1.26B0.0050Positive NewsHigh Trading VolumeAGNCLAGNC InvestmentN/A$24.44+0.1%N/A+10.4%$0.00$1.26B0.0050Positive NewsANSCWAgriculture & Natural Solutions AcquisitionN/A$0.34+17.2%N/AN/A$0.00N/A0.00N/APositive NewsGap UpANSCUAgriculture & Natural Solutions AcquisitionN/A$10.59-0.1%N/AN/A$0.00N/A0.00N/APositive NewsAITRUAI Transportation AcquisitionN/A$10.86flatN/AN/A$0.00N/A0.00N/APositive NewsAITRRAI Transportation AcquisitionN/A$0.11flatN/AN/A$0.00N/A0.00N/APositive News Related Companies and Tools Related Companies AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors Agriculture & Natural Solutions Acquisition Competitors AI Transportation Acquisition Competitors AI Transportation Acquisition Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GPAT) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GP-Act III Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GP-Act III Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
